share_log

Cantor Fitzgerald Reiterates Overweight on Aravive, Maintains $18 Price Target

Benzinga ·  Jul 21, 2023 08:51

Cantor Fitzgerald analyst Louise Chen reiterates Aravive (NASDAQ:ARAV) with a Overweight and maintains $18 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment